intrauterine adhesions
Conditions
Interventions
Group A:Hysteroscopic transuterine resection of adhesion (TCRA)
Group A:4 mg/day oestradiol valerate for 21 days,and 1 mg/d cyproterone acetate was given as artificial cycle treatment for the last 10 days
Group B:Hysteroscopic transuterine resection of adhesion (TCRA)
Group B:100 mg/d aspirin and 4 mg/d oestradiol valerate for 21 days,and artificial cycle treatment of 1 mg/d cyproterone acetate was given during the last 10 days
Sponsors
Xiangyang 1st People's Hospital, Hubei University of Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 38 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed with intrauterine adhesions by hysteroscopy, all patients with a history of infertility and a need for pregnancy, and patients who were reviewed again with good compliance.
Exclusion criteria
Exclusion criteria: Infection, other diseases of the uterus, hormone-dependent diseases and malignant diseases, and patients who received hormone therapy within 3 months before surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uterine length;Endometrium thickness;Menstrual length;Menstrual volume;AFS-score;a-smooth muscle actin;collagen type I a 1 chain;fibronectin;transforming growth factor-beta1;Smad2;phospho-Smad2;phospho-Smad3;Smad3; | — |
Countries
China
Contacts
Public ContactShuang Li
Xiangyang 1st People's Hospital, Hubei University of Medicine
Outcome results
None listed